Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Tombstone - CPL (A)
TMB - CPL (A)
|
2046 | 3B | 2 | 13.0 | 0 | 3 | 0 | 1.000 | 2.08 | 1.044 | 0.24 |
Cayucos - SNL (R)
CAY - SNL (R)
|
2045 | 3B | 53 | 452.1 | 22 | 100 | 5 | .961 | 2.43 | .973 | -2.33 |
Cayucos - SNL (R)
CAY - SNL (R)
|
2045 | SS | 1 | 9.0 | 0 | 4 | 1 | .800 | 4.00 | .887 | -0.11 |
Cayucos - SNL (R)
CAY - SNL (R)
|
2044 | 2B | 45 | 364.1 | 88 | 100 | 3 | .984 | 4.64 | 1.030 | 1.85 |
Pabst - CCAS (COL)
PBR - CCAS (COL)
|
2044 | 2B | 12 | 107.0 | 19 | 20 | 0 | 1.000 | 3.28 | 1.031 | 0.76 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2041 | 2B | 20 | 166.1 | 29 | 30 | 0 | 1.000 | 3.19 | 1.037 | 0.70 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2040 | 2B | 39 | 357.0 | 80 | 82 | 1 | .994 | 4.08 | 1.031 | 2.23 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2040 | 3B | 1 | 8.0 | 1 | 1 | 0 | 1.000 | 2.25 | 1.103 | 0.26 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2039 | 2B | 3 | 25.0 | 4 | 5 | 0 | 1.000 | 3.24 | 1.093 | 0.29 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2039 | 3B | 7 | 66.0 | 4 | 12 | 0 | 1.000 | 2.18 | 1.089 | 0.59 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2039 | LF | 3 | 17.2 | 5 | 0 | 0 | 1.000 | 2.55 | 1.049 | 0.30 |
Total | 2B | 119 | 1019.2 | 220 | 237 | 4 | 5.83 | ||||
Total | 3B | 63 | 539.1 | 27 | 116 | 5 | -1.25 | ||||
Total | SS | 1 | 9.0 | 0 | 4 | 1 | -0.11 | ||||
Total | LF | 3 | 17.2 | 5 | 0 | 0 | 0.30 |